Mutant PIK3CA-bearing colon cancer cells display increased metastasis in an orthotopic model

Xiao Ning Guo, Ashwani Rajput, Rebecca Rose, Jennie Hauser, Alexander Beko, Karen Kuropatwinski, Charles LeVa, Robert M. Hoffman, Michael G. Brattain, Jing Wang

Research output: Contribution to journalArticle

49 Citations (Scopus)

Abstract

Mutations in the PIK3CA gene are common in human cancers, including colon cancer. We compared two pairs of colon cancer cells (HCT116 and DLD1) bearing only the wild-type (WT) or mutant (MUT) PIK3CA allele for their survival capacity under stress conditions in vitro as well as their metastatic properties in an in vivo orthotopic model. When subjected to growth factor deprivation stress (GFDS), the MUT PIK3CA cells displayed resistance to GFDS-induced apoptosis relative to the WT cells. Phosphatidylinositol 3-kinase (PI3K) and its down-stream effector AKT were constitutively activated during stress conditions in the MUT PIK3CA cells but not in the WT cells. The MUT cells showed hypersensitivity to PI3K inhibition. Moreover, the proapoptotic protein Bax was expressed at a very high level in the WT PIK3CA cells, whereas it was almost undetectable in the MUT cells. Inhibition of Bax expression by small interfering RNA protected the WT PIK3CA cells from GFDS-induced apoptosis, suggesting an important role of Bax in GFDS-induced apoptosis. These results indicated that the MUT PI3K confers resistance to GFDS-induced apoptosis and that the MUT cells are more dependent on the PI3K pathway for survival. In vivo studies showed that the MUT PIK3CA-bearing cells were more metastatic than the WT cells in an orthotopic model of colon cancer. Taken together, these results suggest that MUT PI3K imparts a more aggressive phenotype in colon cancer cells and could be a potential therapeutic target for treatment of colon cancer patients bearing PIK3CA mutations.

Original languageEnglish (US)
Pages (from-to)5851-5858
Number of pages8
JournalCancer Research
Volume67
Issue number12
DOIs
StatePublished - Jun 15 2007

Fingerprint

Colonic Neoplasms
Neoplasm Metastasis
Phosphatidylinositol 3-Kinase
Intercellular Signaling Peptides and Proteins
Apoptosis
HCT116 Cells
bcl-2-Associated X Protein
Mutation
Survival
Small Interfering RNA
Hypersensitivity
Alleles
Phenotype

ASJC Scopus subject areas

  • Oncology
  • Cancer Research

Cite this

Guo, X. N., Rajput, A., Rose, R., Hauser, J., Beko, A., Kuropatwinski, K., ... Wang, J. (2007). Mutant PIK3CA-bearing colon cancer cells display increased metastasis in an orthotopic model. Cancer Research, 67(12), 5851-5858. https://doi.org/10.1158/0008-5472.CAN-07-0049

Mutant PIK3CA-bearing colon cancer cells display increased metastasis in an orthotopic model. / Guo, Xiao Ning; Rajput, Ashwani; Rose, Rebecca; Hauser, Jennie; Beko, Alexander; Kuropatwinski, Karen; LeVa, Charles; Hoffman, Robert M.; Brattain, Michael G.; Wang, Jing.

In: Cancer Research, Vol. 67, No. 12, 15.06.2007, p. 5851-5858.

Research output: Contribution to journalArticle

Guo, XN, Rajput, A, Rose, R, Hauser, J, Beko, A, Kuropatwinski, K, LeVa, C, Hoffman, RM, Brattain, MG & Wang, J 2007, 'Mutant PIK3CA-bearing colon cancer cells display increased metastasis in an orthotopic model', Cancer Research, vol. 67, no. 12, pp. 5851-5858. https://doi.org/10.1158/0008-5472.CAN-07-0049
Guo, Xiao Ning ; Rajput, Ashwani ; Rose, Rebecca ; Hauser, Jennie ; Beko, Alexander ; Kuropatwinski, Karen ; LeVa, Charles ; Hoffman, Robert M. ; Brattain, Michael G. ; Wang, Jing. / Mutant PIK3CA-bearing colon cancer cells display increased metastasis in an orthotopic model. In: Cancer Research. 2007 ; Vol. 67, No. 12. pp. 5851-5858.
@article{aa6c32b7811f482c92efdb058e966dfd,
title = "Mutant PIK3CA-bearing colon cancer cells display increased metastasis in an orthotopic model",
abstract = "Mutations in the PIK3CA gene are common in human cancers, including colon cancer. We compared two pairs of colon cancer cells (HCT116 and DLD1) bearing only the wild-type (WT) or mutant (MUT) PIK3CA allele for their survival capacity under stress conditions in vitro as well as their metastatic properties in an in vivo orthotopic model. When subjected to growth factor deprivation stress (GFDS), the MUT PIK3CA cells displayed resistance to GFDS-induced apoptosis relative to the WT cells. Phosphatidylinositol 3-kinase (PI3K) and its down-stream effector AKT were constitutively activated during stress conditions in the MUT PIK3CA cells but not in the WT cells. The MUT cells showed hypersensitivity to PI3K inhibition. Moreover, the proapoptotic protein Bax was expressed at a very high level in the WT PIK3CA cells, whereas it was almost undetectable in the MUT cells. Inhibition of Bax expression by small interfering RNA protected the WT PIK3CA cells from GFDS-induced apoptosis, suggesting an important role of Bax in GFDS-induced apoptosis. These results indicated that the MUT PI3K confers resistance to GFDS-induced apoptosis and that the MUT cells are more dependent on the PI3K pathway for survival. In vivo studies showed that the MUT PIK3CA-bearing cells were more metastatic than the WT cells in an orthotopic model of colon cancer. Taken together, these results suggest that MUT PI3K imparts a more aggressive phenotype in colon cancer cells and could be a potential therapeutic target for treatment of colon cancer patients bearing PIK3CA mutations.",
author = "Guo, {Xiao Ning} and Ashwani Rajput and Rebecca Rose and Jennie Hauser and Alexander Beko and Karen Kuropatwinski and Charles LeVa and Hoffman, {Robert M.} and Brattain, {Michael G.} and Jing Wang",
year = "2007",
month = "6",
day = "15",
doi = "10.1158/0008-5472.CAN-07-0049",
language = "English (US)",
volume = "67",
pages = "5851--5858",
journal = "Cancer Research",
issn = "0008-5472",
publisher = "American Association for Cancer Research Inc.",
number = "12",

}

TY - JOUR

T1 - Mutant PIK3CA-bearing colon cancer cells display increased metastasis in an orthotopic model

AU - Guo, Xiao Ning

AU - Rajput, Ashwani

AU - Rose, Rebecca

AU - Hauser, Jennie

AU - Beko, Alexander

AU - Kuropatwinski, Karen

AU - LeVa, Charles

AU - Hoffman, Robert M.

AU - Brattain, Michael G.

AU - Wang, Jing

PY - 2007/6/15

Y1 - 2007/6/15

N2 - Mutations in the PIK3CA gene are common in human cancers, including colon cancer. We compared two pairs of colon cancer cells (HCT116 and DLD1) bearing only the wild-type (WT) or mutant (MUT) PIK3CA allele for their survival capacity under stress conditions in vitro as well as their metastatic properties in an in vivo orthotopic model. When subjected to growth factor deprivation stress (GFDS), the MUT PIK3CA cells displayed resistance to GFDS-induced apoptosis relative to the WT cells. Phosphatidylinositol 3-kinase (PI3K) and its down-stream effector AKT were constitutively activated during stress conditions in the MUT PIK3CA cells but not in the WT cells. The MUT cells showed hypersensitivity to PI3K inhibition. Moreover, the proapoptotic protein Bax was expressed at a very high level in the WT PIK3CA cells, whereas it was almost undetectable in the MUT cells. Inhibition of Bax expression by small interfering RNA protected the WT PIK3CA cells from GFDS-induced apoptosis, suggesting an important role of Bax in GFDS-induced apoptosis. These results indicated that the MUT PI3K confers resistance to GFDS-induced apoptosis and that the MUT cells are more dependent on the PI3K pathway for survival. In vivo studies showed that the MUT PIK3CA-bearing cells were more metastatic than the WT cells in an orthotopic model of colon cancer. Taken together, these results suggest that MUT PI3K imparts a more aggressive phenotype in colon cancer cells and could be a potential therapeutic target for treatment of colon cancer patients bearing PIK3CA mutations.

AB - Mutations in the PIK3CA gene are common in human cancers, including colon cancer. We compared two pairs of colon cancer cells (HCT116 and DLD1) bearing only the wild-type (WT) or mutant (MUT) PIK3CA allele for their survival capacity under stress conditions in vitro as well as their metastatic properties in an in vivo orthotopic model. When subjected to growth factor deprivation stress (GFDS), the MUT PIK3CA cells displayed resistance to GFDS-induced apoptosis relative to the WT cells. Phosphatidylinositol 3-kinase (PI3K) and its down-stream effector AKT were constitutively activated during stress conditions in the MUT PIK3CA cells but not in the WT cells. The MUT cells showed hypersensitivity to PI3K inhibition. Moreover, the proapoptotic protein Bax was expressed at a very high level in the WT PIK3CA cells, whereas it was almost undetectable in the MUT cells. Inhibition of Bax expression by small interfering RNA protected the WT PIK3CA cells from GFDS-induced apoptosis, suggesting an important role of Bax in GFDS-induced apoptosis. These results indicated that the MUT PI3K confers resistance to GFDS-induced apoptosis and that the MUT cells are more dependent on the PI3K pathway for survival. In vivo studies showed that the MUT PIK3CA-bearing cells were more metastatic than the WT cells in an orthotopic model of colon cancer. Taken together, these results suggest that MUT PI3K imparts a more aggressive phenotype in colon cancer cells and could be a potential therapeutic target for treatment of colon cancer patients bearing PIK3CA mutations.

UR - http://www.scopus.com/inward/record.url?scp=34250835879&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=34250835879&partnerID=8YFLogxK

U2 - 10.1158/0008-5472.CAN-07-0049

DO - 10.1158/0008-5472.CAN-07-0049

M3 - Article

C2 - 17575153

AN - SCOPUS:34250835879

VL - 67

SP - 5851

EP - 5858

JO - Cancer Research

JF - Cancer Research

SN - 0008-5472

IS - 12

ER -